ArticleClinics (Sao Paulo, Brazil)2026
Clinical and inflammatory factors associated with prevalent gout in a Brazilian hospital population.
Article in Clinics (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveGout is a rheumatological disease characterized by the crystallization of uric acid (UA) in joints and tissues, which is believed to trigger inflammatory responses. This study aimed to characterize the inflammatory profile of gout patients in a Brazilian population and its potential influence on flare frequency.
methodsIn this observational cross-sectional study, we analyzed 193 patients from the Complex of Clinics Hospital in Curitiba, Brazil, categorized into two groups: gout (n = 102) and non-gout (n = 91). Data were obtained through in-person surveys, consultation of medical records, and serum analyses. We evaluated anthropometric measurements, lifestyle habits, medication use, serum UA levels, and cytokine profiles.
resultsMales were more prevalent in the gout group than in the non-gout group (p < 0.001). The gout group also showed higher consumption of uricogenic foods, including ethanol (p = 0.006), sugary drinks (p = 0.001), meat and seafood (p < 0.001), and processed meats (p = 0.034). UA levels were not correlated with cytokine presence and were not effective in distinguishing patients with low or high flare frequency (OR = 1.07; p = 0.6; AUC = 0.522). IL-6 levels alone modestly differentiated flare frequency (OR = 0.99; p = 0.8; AUC = 0.788), with improved discrimination when combined with monocyte counts (OR = 0.84; p = 0.029; AUC = 0.801).
conclusionsIL-6, particularly when combined with monocyte count, may be worth considering as a potential marker of gout flare frequency, enabling earlier identification of high-risk patients and supporting targeted interventions to improve disease management and outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.